Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All Resources
Filters
Select resource types
Select products & services
Select solutions (2)
Active Filters (2)
Clear All
145 - 156 of 164 Results
Sort by:
Best Match
Whitepaper
Shifting the treatment paradigm: the promise of gene therapy for neurodegenerative diseases
Traditional treatments for neurodegenerative diseases focus on managing symptoms, but recent advancements in gene therapy offer hope for more effective and sustainable solutions. Read now!
Whitepaper
Targeted protein degradation: A novel therapeutic strategy for neurodegenerative diseases
In this white paper, get details about TPD that offers a novel strategy for neurodegenerative diseases by degrading disease-linked proteins, showing promise in preclinical studies.
Whitepaper
Exploring the strengths, challenges, and therapeutic applications of multispecific antibodies
Discover the latest advancements in multispecific antibodies and their transformative potential in treating complex diseases. Download our comprehensive white paper now!
Application Note
Biochemical binding ADCC assays utilizing AlphaLISA toolbox reagents for the characterization of hIgGs and FcγR1A
In this application note we demonstrate the ease with which AlphaLISA toolbox reagents can be used to develop any FcγR binding assay across the various stages of biologics research and development, including therapeutic screening and GMP Lot Release.
Application Note
A fast and simple chemiluminescent assay for monitoring of DNA-protein interactions
In this application note, we use HepG2 nuclear extracts to demonstrate the binding of Sp1 and HNF1 transcription factors to tagged oligonucleotides containing required cognate response elements. Read this note to see the results and access detailed data compared to EMSA.
Technical Note
AlphaLISA Acetyl‑Histone H3 lysine 27 (H3K27ac) cellular detection kit
This AlphaLISA immunodetection assay detects alterations in acetylated histone H3 lysine 27 (H3K27ac) levels within cellular extracts.
Guide
The issue of CHO HCPs during biopharmaceutical production
Detecting and quantifying CHO HCPs with automatable homogeneous immunoassays
Application Note
Advantages of using our automatable and no-wash HTRF and AlphaLISA kits for CHO HCP detection
Read this application note to learn about CHO HCP impurity quantification using AlphaLISA and HTRF technologies
Flyer
Advance your biologics research with Revvity solutions
Revvity’s no-wash tools empower biotherapeutics research—from screening to biomanufacturing. Discover precision and efficiency.
Infographic
Safety rules with Revvity biotherapeutic workflows
Improve safety and efficacy of your GMP manufacturing workflows with this infographic exploring Revvity instruments, reagents and assays.
Flyer
Host cell contamination detection flyer
Be safe in quantifying residual host cell DNA and proteins when developing your next biologic, cell or gene therapy.
Whitepaper
Learning from our ancestors: can we be better prepared for the next pandemic?
Researchers have found evidence of an ancient viral epidemic involving host coronavirus interacting genes in East Asia more than 20,000 years ago. These findings could help countries prepare for future pandemics.
Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.